The Joint Preservation Institute of Iowa is now offering stem cell therapy in Des Moines.
Dr. Goding is one of the firstorthopaedic surgeons in the nation to offer this treatment. He uses autologous stem cell therapy and the regenerative power of mesenchymal stem cells to give patients another treatment option for dealing with orthopaedic conditions, such as osteoarthritis and other degenerative joint conditions.
You may benefit from orthopaedic stem cell therapy if you have:
Mesenchymal stem cells (MSCs) are adult stem cells found in bone marrow. The Joint Preservation Institute of Iowa performs autologous stem cell therapy, which means that the stem cells used in your treatment are taken from your own body, not from a donor. Using your own stem cells for the procedure helps reduce your risk of infection and eliminate the possibility of immune rejection.
In an autologous stem cell procedure, Dr. Goding will draw a sample of bone marrow from the iliac crest of your hip. The sample is filtered and concentrated in a sterile environment, then injected into the area of your body needing help to heal. This procedure is done on an outpatient basis while under sedation and leaves no scarring.
The idea behind orthopaedic stem cell therapy is that the injection of these concentrated regenerative cells at an area of your body experiencing degeneration will kick-start your bodys ability to heal itself. These injections can be given as an independent treatment or in conjunction with a surgical procedure.
Most cells in the human body have an assigned purpose. They are liver cells, fat cells, bone cells and so on. These cells can replicate more of their own kind, but they cannot create another type of cell.
Stem cells are the primitive cells from which all other cells developed. They are undifferentiated cells with the ability not only to self-replicate, but also to become different types of human cells. There are several types of stem cells, but the kind used in orthopaedic stem cell therapy are called mesenchymal stem cells (MSCs).
Bone Marrow Concentrate
Dr. Goding uses the BioCUE system from Zimmer Biomet. This system produces 77.5% recovery of nucleated cells.
Higher available cell numbers have correlated with improved results.
Autologous Protein Solution (APS)
APS is the newest treatment in the field of injectable orthobiologics. This procedure is essentially a further processing of platelet rich protein (PRP).
The tremendous advantage of APS is that it is derived from the blood instead of bone marrow. It is less painful, has less potential for injury, is less costly and it provides similar results.
After APS is derived from the blood, it is processed into PRP and then processed into APC. Using APC prevents macrophage cells from destroying healthy cartilage cells and has a profound anti-inflammatory effect in the joint. It also promotes growth and health of existing cartilage cells.
A recent study has shown up to 70 % pain reduction at 6 months in patients undergoing this procedure.
Dr. Goding uses the nSTRIDE system for APS treatments. An MSC has strong potential for tissue repair because it can:
In medical research, tissues such as muscles, cartilage, tendons and ligaments have shown some capacity for self repair. As a result, tissue engineering and the use of MSCs and/or bio-active molecules, such as growth factors, are being tested and studied to determine the role they can play in tissue regeneration and repair.
Articular Cartilage Damage to the articular cartilage following an injury has poor potential for repair and can lead to arthritic changes many years later. Recent studies have shown favorable outcomes and better knee scores at two-year follow ups for bone marrow derived MSCs that those of current techniques of microfracture and autologous chondrocyte implantation.
Bone Trauma and some pathological conditions can lead to extensive bone loss, which requires transplantation of bone and other bone substitutes to restore structural integrity. A large number of studies have shown great potential for mesenchymal cells to repair critically sized bone defects, producing better bone growth and more robust bone formation than controlled groups.
Tendons and Ligaments Injuries to tendons and ligaments heal by forming new tissues of inferior quality. Autografts, allografts and resorbable materials have been used to repair defects in tendons and ligaments, but these carry risks, such as donor site morbidity, scar formation and tissue rejection. A number of studies on the use of MSCs to improve the repair of tendons and tendon defects have been carried out with favorable results when measured in histology and tissue strength. The use of mesenchymal cells with tissue allografts enhances the graft and improves the biomechanical properties compared to control studies.
Meniscus Most tears of the meniscus occur in avascular zones with little or no potential for repair. Standard biological healing processes produce limited results and meniscectomy (removal of all or part of the torn meniscus) has been shown to have a strong association with subsequent development of osteoarthritis. Recently, studies have shown that self-paced therapy, including MSCs, demonstrates biological healing and adherence of meniscal tears in avascular zones.
Initial Visit An initial consultation with Dr. Goding will be required to find out if you are a candidate for stem cell therapy. In some cases, an MRI may be recommended to confirm your diagnosis and rule out any underlying conditions that could cause complications. If you are determined to be a candidate for stem cell therapy, your procedure will be scheduled for another day. This initial consultation is usually covered by your insurance plan.
Preparation For two weeks prior to your procedure, do not take aspirin or anti-inflammatory medications (NSAIDS).
Procedure Stand-alone stem cell therapy is done as an outpatient procedure, so most patients will leave the clinic and resume low impact activities the same day. Some patients have reported mild pain for 48-72 hours after their procedure, but this can often be attributed to the absence of their routine anti-inflammatory medications. After this time period, most patients will experience a gradual decrease in pain and some may begin to notice increased function.
Post-procedure To give your procedure the best chance to provide lasting results, our physicians recommend the following post-procedure restrictions:
Please note: If you are having a stem cell therapy procedure in conjunction with another surgical procedure, your recommendations may change. Consult with your physician on the guidelines and restrictions for your specific case.
No. Because mesenchymal stem cell (MSC) injections are considered investigational for orthopaedic applications, most insurance companies will not cover the cost. Please contact our office to discuss cash payment options.
Go here to read the rest:
Stem Cells - Joint Preservation Institute of Iowa
- White Blood Cells (WBCs) - Definition, Function, and Ranges - August 22nd, 2022
- Cancer requires more tutoring, with Meyer continuing to Teaching Cancer a lesson - News - vintontoday.com - January 20th, 2021
- Huntington's Disease Alters Human Development in the Fetal... : Neurology Today - LWW Journals - August 26th, 2020
- Science Becomes A Dividing Issue In Year Of Election And Pandemic - Iowa Public Radio - April 29th, 2020
- Lost Smell and Taste Hint COVID-19 Can Target the Nervous System - The Scientist - March 29th, 2020
- Stem Cell Treatment for Cartilage Regeneration ... - March 14th, 2020
- UI doctors discover new genetic mutation that causes fatal heart arrhythmias - UI The Daily Iowan - February 22nd, 2020
- What will the US look like in 2030? | Articles - telegraphherald.com - February 9th, 2020
- Red Shamrock: Fight never over, even when kids beat cancer - Iowa City Press-Citizen - January 9th, 2020
- Biden Exaggerates Science on Burn Pits and Brain Cancer - FactCheck.org - December 22nd, 2019
- Fate Therapeutics Inc. (FATE) and KemPharm Inc. (NASDAQ:KMPH) Comparison side by side - The EN Herald - September 23rd, 2019
- Common Prostate Drug May Slow Progression of Parkinson, Researchers Say - AJMC.com Managed Markets Network - September 23rd, 2019
- Contrasting of Cellular Biomedicine Group Inc. (CBMG) and KemPharm Inc. (NASDAQ:KMPH) - The EN Herald - September 23rd, 2019
- Our Team - Neural Stem Cell Institute, Rensselaer NY - April 12th, 2019
- Cultured meat - Wikipedia - January 20th, 2019
- Stem Cell - Joint Preservation Institute of Iowa - August 9th, 2018
- Stem cell therapy and healing meniscus damage - Dr. Marc ... - July 29th, 2018
- The importance of stem cell numbers in stem cell therapy ... - July 17th, 2018
- Blood and Marrow Transplant Program | University of Iowa ... - July 15th, 2018
- Regenexx Des Moines | Iowa's Regenexx Provider - October 15th, 2017
- US record holder for most time in space Peggy Whitson returns to Earth after 288-day mission - Pulse Headlines - September 3rd, 2017
- FDA Cracks Down On Stem-Cell Clinics Selling Unapproved Treatments - Iowa Public Radio - September 3rd, 2017
- Stem cells: JP2MRI, CET discover safer, more ethical biotechnology - Sioux City Catholic Globe - July 2nd, 2017
- Mesenchymal Stem Cell Therapy - Cedar Rapids, Iowa City ... - November 10th, 2016
- Des Moines, Iowa Stem Cell Transplants, Clive, Grimes ... - November 8th, 2016
- Stem Cell Research | Environmental Health and Safety - October 21st, 2016
- Molecular imaging of stem cells | StemBook - August 23rd, 2016
- Telomere elongation in induced pluripotent stem cells from ... - October 19th, 2015
- Hair Loss Cure One Step Closer To Reality; Scientists Grow ... - October 19th, 2015
- Are Cancer Stem Cells the Key to Discovering a Cure ... - October 6th, 2015
- University of Iowa Stem Cell Group - October 6th, 2015
- Stem Cells + HA New Injection for Knees?; Fracture Repair ... - September 27th, 2015
- Des Moines IA Resources - Stem Cells: Get Facts on ... - July 2nd, 2015
- Stem Cell Banking Market in India 2015-2019 - Sioux City ... - June 10th, 2015
- How Do Stem Cells Help Cure Parkinson's Disease? | eHow - March 18th, 2015
- UI researchers tout diabetes development - January 29th, 2015
- stem cell research | LVATUG blog - December 16th, 2014
- NYSCF and the CMTA enter collaboration to advance neuropathies research - December 11th, 2014
- stem cell - FierceBiotech - Biotech Industry, Biotech News ... - December 2nd, 2014
- IOWA AND STEM CELLS: Braley/Ernst Race has National Impact - October 21st, 2014
- Genesis launches new Neuroscience Institute - October 1st, 2014
- Cedar Rapids IA Resources - Stem Cells: Get Facts on Uses ... - September 24th, 2014
- Institute has raised $400K in donations - September 20th, 2014
- Iowa City-area institute gets $400,000 from Ice Bucket ... - September 13th, 2014
- ISU Bioethics Outreach--Stem Cells - Iowa State University - September 13th, 2014
- Ames IA Stem Cell Treatment | Ames Iowa Cancer Stem Cell ... - September 5th, 2014
- Iowa opens new debate over use of stem cells - September 1st, 2014
- Catholics asked to NOT donate to the ALS Association - August 29th, 2014
- Catholic Church At Odds With Ice Bucket Challenge - August 26th, 2014
- Why some are wary about doing ALS challenge - August 23rd, 2014
- Archdiocese of St. Louis warning about the, Ice Bucket Challenge - August 23rd, 2014
- Iowa Stem Cell Therapy | Stem Cell Treatments - August 22nd, 2014
- Ohio diocese discourages ice bucket challenge - August 22nd, 2014